Human Trial for OST-HER2

from MIB Agents OsteoBites and osTEAo · host MIB Agents Osteosarcoma

Today we talk with Dr. Damon Reed from Moffit Cancer Center and Dr. Nicola Mason from  University of Pennsylvania School of Veterinary Medicine about the promising results from a multi-institutional clinical trial evaluating the safety and efficacy of a recombinant Listeria to prevent metastatic disease in dogs with osteosarcoma, and how that will translate to a human trial.   #clinicaltrials #osteosarcoma #cancerupdates

Episode metadata supplied by the publisher feed · Published Feb 11, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Human Trial for OST-HER2

0:00 1:00:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MIB Agents OsteoBites and osTEAo?

This episode is 1 hour and 0 minutes long.

When was this MIB Agents OsteoBites and osTEAo episode published?

This episode was published on February 11, 2022.

Can I download this MIB Agents OsteoBites and osTEAo episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!